Clinical trial
Efficacy Study of Galantamine for Cognitive Impairments in Schizophrenia
NCT00176423
Study timeline
Study start (actual)2002-05-01Date precision: month
Registry last updated2020-12-16
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Schizophreniaunresolved
Schizoaffective Disorderunresolved
Interventions
galantamineDRUG · verified · RxNorm: galantamine
Sponsors & collaborators
University of Maryland, Baltimorelead sponsor
Stanley Medical Research Institutecollaborator
Ortho-McNeil Neurologics, Inc.collaborator
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT00176423 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.